Literature DB >> 27203488

Expanding the benefits of HPV vaccination to boys and men.

Kathleen M Schmeler1, Erich M Sturgis2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27203488     DOI： 10.1016/S0140-6736(16)30314-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Incidence of external genital lesions related to human papillomavirus among Mexican men. A cohort study.

Authors:  Eduardo Lazcano-Ponce; Staci L Sudenga; B Nelson Torres; Mark Stoler; Leith León-Maldonado; Betania Allen-Leigh; Héctor Posso; Manuel Quiterio; María Del Pilar Hernández-Nevarez; Jorge Salmerón; Anna R Giuliano
Journal:  Salud Publica Mex       Date:  2018 Nov-Dec

2.  Parents' views of including young boys in the Swedish national school-based HPV vaccination programme: a qualitative study.

Authors:  Maria Gottvall; Christina Stenhammar; Maria Grandahl
Journal:  BMJ Open       Date:  2017-02-28       Impact factor: 2.692

3.  Global Pattern and Trends in Penile Cancer Incidence: Population-Based Study.

Authors:  Leiwen Fu; Tian Tian; Kai Yao; Xiang-Feng Chen; Ganfeng Luo; Yanxiao Gao; Yi-Fan Lin; Bingyi Wang; Yinghui Sun; Weiran Zheng; Peiyang Li; Yuewei Zhan; Christopher K Fairley; Andrew Grulich; Huachun Zou
Journal:  JMIR Public Health Surveill       Date:  2022-07-06

4.  Low awareness of HPV infection and willingness of HPV vaccination among Chinese male college students in the east of China.

Authors:  Hu Ran; Yue Chen; Jun Gao; Hongxiong Guo; Shanshan Peng
Journal:  Front Public Health       Date:  2022-09-20

5.  Safety profile of the 9-valent human papillomavirus vaccine: assessment in prior quadrivalent HPV vaccine recipients and in men 16 to 26 years of age.

Authors:  E D Moreira; A R Giuliano; J de Hoon; O-E Iversen; E A Joura; J Restrepo; P Van Damme; C Vandermeulen; M C Ellison; A Krick; C Shields; B Heiles; A Luxembourg
Journal:  Hum Vaccin Immunother       Date:  2017-12-14       Impact factor: 3.452

6.  Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women.

Authors:  Ángela María Ruiz-Sternberg; Edson D Moreira; Jaime A Restrepo; Eduardo Lazcano-Ponce; Robinson Cabello; Arnaldo Silva; Rosires Andrade; Francisco Revollo; Santos Uscanga; Alejandro Victoria; Ana María Guevara; Joaquín Luna; Manuel Plata; Claudia Nossa Dominguez; Edison Fedrizzi; Eugenio Suarez; Julio C Reina; Misoo C Ellison; Erin Moeller; Michael Ritter; Christine Shields; Miguel Cashat; Gonzalo Perez; Alain Luxembourg
Journal:  Papillomavirus Res       Date:  2017-12-19

7.  HPV-Specific Systemic Antibody Responses and Memory B Cells are Independently Maintained up to 6 Years and in a Vaccine-Specific Manner Following Immunization with Cervarix and Gardasil in Adolescent and Young Adult Women in Vaccination Programs in Italy.

Authors:  Francesco Nicoli; Barbara Mantelli; Eleonora Gallerani; Valentina Telatin; Irene Bonazzi; Peggy Marconi; Riccardo Gavioli; Liliana Gabrielli; Tiziana Lazzarotto; Luisa Barzon; Giorgio Palù; And Antonella Caputo
Journal:  Vaccines (Basel)       Date:  2020-01-14

Review 8.  Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review.

Authors:  Thomas Harder; Ole Wichmann; Stefanie J Klug; Marianne A B van der Sande; Miriam Wiese-Posselt
Journal:  BMC Med       Date:  2018-07-18       Impact factor: 8.775

9.  Genital Human Papillomavirus Prevalence and Genotyping Among Males in Putuo District of Shanghai, China 2015-2019.

Authors:  Xiaoxiao Li; Fenfen Xiang; Zixi Chen; Tao Zhang; Zhaowei Zhu; Mengzhe Zhang; Rong Wu; Xiangdong Kang
Journal:  Med Sci Monit       Date:  2021-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.